Document:

ex10_1.htm

  
    Exhibit
10.1

     

    

    

    

     

    Songzai
International Holding Group, Inc.

    

    2009
Stock Incentive Plan

    

    

    

    

    

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    

    SONGZAI
INTERNATIONAL HOLDING GROUP, INC.

    2009
STOCK INCENTIVE PLAN

    

    TABLE
OF CONTENTS

     

    
      
        	
                Section

              	 
      	 
      	 
      	
                Page

                 

              
	
                1.

              	 
      	
                Establishment,
      Purpose, and Duration

              	 
      	
                1

              
	 
      	 
      	 
      	 
      	 
      
	
                2.

              	 
      	
                Definitions

              	 
      	
                1

              
	 
      	 
      	 
      	 
      	 
      
	
                3.

              	 
      	
                Administration

              	 
      	
                6

              
	 
      	 
      	 
      	 
      	 
      
	
                4.

              	 
      	
                Shares
      Subject to this Plan

              	 
      	
                6

              
	 
      	 
      	 
      	 
      	 
      
	
                5.

              	 
      	
                Eligibility
      and Participation

              	 
      	
                7

              
	 
      	 
      	 
      	 
      	 
      
	
                6.

              	 
      	
                Stock
      Options

              	 
      	
                7

              
	 
      	 
      	 
      	 
      	 
      
	
                7.

              	 
      	
                Stock
      Awards

              	 
      	
                9

              
	 
      	 
      	 
      	 
      	 
      
	
                8.

              	 
      	
                Performance
      Awards and Performance Measures

              	 
      	
                10

              
	 
      	 
      	 
      	 
      	 
      
	
                9.

              	 
      	
                Rights
      of Participants

              	 
      	
                13

              
	 
      	 
      	 
      	 
      	 
      
	
                10.

              	 
      	
                Termination
      of Employment/Directorship/Consultancy

              	 
      	
                13

              
	 
      	 
      	 
      	 
      	 
      
	
                11.

              	 
      	
                Change
      in Control

              	 
      	
                14

              
	 
      	 
      	 
      	 
      	 
      
	
                12.

              	 
      	
                Plan
      Effective Date, Amendment, Modification, and Termination

              	 
      	
                15

              
	 
      	 
      	 
      	 
      	 
      
	
                13.

              	 
      	
                Withholding

              	 
      	
                15

              
	 
      	 
      	 
      	 
      	 
      
	
                14.

              	 
      	
                Successors

              	 
      	
                16

              
	 
      	 
      	 
      	 
      	 
      
	
                15.

              	 
      	
                General
      Provisions

              	 
      	
                16

              

      

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    1.            
ESTABLISHMENT, PURPOSE, AND DURATION

     

    1.1           Establishment of
Plan.  Songzai International Holding Group, Inc., a Nevada corporation (the “Company”), hereby adopts the
“Songzai International Holding Group, Inc. 2009 Stock Incentive Plan”
(hereinafter referred to as the “Plan”), as set forth
in this document.

     

    1.2           Purpose.  The
purpose of this Plan is to advance the interests of the Company’s shareholders
by enhancing the Company’s ability to attract, retain and motivate persons who
are expected to make important contributions to the Company and by providing
such persons with equity ownership opportunities and performance-based
incentives and thereby better aligning the interests of such persons with those
of the Company’s shareholders.

     

    1.3           Duration of
Plan.  This Plan shall remain in effect, subject to the right
of the Committee to amend or terminate this Plan at any time pursuant to
Section 12 hereof, until the earliest of (a) such time as no Shares remain
available for issuance under the Plan, (b) termination of this Plan by the
Board, or (c) the tenth anniversary of the Effective Date. Awards outstanding
upon expiration of the Plan shall remain in effect until they have been
exercised or terminated, or have expired.

     

    2.            
DEFINITIONS

     

    Whenever
used in this Plan, the following terms shall have the meanings set forth below,
and when the meaning is intended, the initial letter of the word shall be
capitalized:

     

    2.1           “Award” means, individually or
collectively, a grant under this Plan of Nonqualified Stock Options,
Incentive Stock Options, Stock Awards or Performance Awards.

     

    2.2           “Award Agreement” means a
written agreement entered into by the Company and a Participant setting forth
the terms and provisions applicable to an Award granted under this
Plan.

     

    2.3           “Beneficial Owner” or “Beneficial Ownership” shall
have the meaning ascribed to such term in Rule 13d-3 of the General Rules and
Regulations under the Exchange Act.

     

    2.4           “Board” or “Board of Directors” means the
Board of Directors of the Company.

     

    2.5           “Change in Control” shall be
deemed to have occurred under any one or more of the following
conditions:

     

    (a)           if,
within one year of any merger, consolidation, sale of a substantial part of the
Company’s assets, or contested election, or any combination of the foregoing
transactions (a “Transaction”), the persons who
were Directors of the Company immediately before the Transaction shall cease to
constitute a majority of the Board of Directors (x) of the Company or (y) of any
successor to the Company, or (z) if the Company becomes a subsidiary of or is
merged into or consolidated with another corporation, of such corporation (the
Company shall be deemed a subsidiary of such other corporation if such other
corporation owns or controls, directly or indirectly, a majority of the combined
voting power of the outstanding shares of the capital stock of the Company
entitled to vote generally in the election of directors (“Voting Stock”));

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

     

    (b)           if,
as a result of a Transaction, the Company does not survive as an entity, or its
shares are changed into the shares of another corporation unless the
shareholders of the Company immediately prior to the Transaction own a majority
of the outstanding shares of such other corporation immediately following the
Transaction;

    

    (c)           if
any Person becomes, after the date this Plan is adopted, a beneficial owner
directly or indirectly of securities of the Company representing 50% or more of
the combined voting power of the Company’s Voting Stock;

    

    (d)           the
dissolution or liquidation of the Company is approved by its shareholders;
or

    

    (e)           if
the members of the Board as of the date this Plan is adopted (the “Incumbent Board”) cease to
represent at least two-thirds of the Board; provided, that any person becoming a
director subsequent to the date hereof whose election, or nomination for
election by the Company’s s, was approved by at least two-thirds of the members
comprising the Incumbent Board (either by a specific vote or by approval of the
proxy statement in which such person is named as a nominee for director without
objection to such nomination) shall be, for purposes of this paragraph (v),
treated as though such person were a member of the Incumbent Board.

     

    2.6           “Code” means the U.S. Internal
Revenue Code of 1986, as amended from time to time.

     

    2.7           “Committee” means the
Compensation Committee of the Board or such other committee appointed from time
to time by the Board to administer this Plan. The full Board of Directors, in
its discretion, may act as the Committee under this Plan, whether or not a
Committee has been appointed, and shall do so with respect to grants of Awards
to Non-Employee Directors. To the extent permitted by law, the Committee may
delegate to one or more members of the Committee or officers of the Company,
individually or acting as a committee, any portion of its authority, except as
otherwise expressly provided in this Plan. In the event of a delegation to one
or more members of the Committee or an officer, the term “Committee” as used herein
shall include the member or members of the Committee or officer with respect to
the delegated authority. Notwithstanding any such delegation of authority, the
Committee comprised of members of the Board of Directors and appointed by the
Board of Directors shall retain overall responsibility for the operation of this
Plan.

    

    2.8           “Company” means Songzai
International Holding Group, Inc., a Nevada corporation and any successor
thereto as provided in Section 14 hereof.

    

    2.9           “Consultant” means any person
(other than an Employee or a Director, solely with respect to rendering services
in such person’s capacity as a director) who is engaged by the Company to render
services, including but not limited to advisory or consulting services, to the
Company.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    2.10           “Continuous Service” means the
uninterrupted provision of services to the Company in any capacity of Employee,
Director or Consultant.  Continuous Service shall not be considered to
be interrupted in the case of (i) any approved leave of absence, (ii) transfers
among the Company, or any successor entities, in any capacity of Employee,
Director or Consultant, or (iii) any change in status as long as the individual
remains in the service of the Company in any capacity of Employee, Director or
Consultant (except as otherwise provided in the Award Agreement).  An
approved leave of absence shall include sick leave, military leave, or any other
authorized personal leave.

    

    2.11           “Covered Employee” means a
Participant who, as of the date of vesting and/or payout of an Award, or the
date the Company is entitled to a tax deduction as a result of the Award, as
applicable, is one of the group of “covered employees,” as defined in the
regulations promulgated under Code Section 162(m), or any successor
statute.

     

    2.12           “Director” means any
individual who is a member of the Board of Directors of the Company; provided,
however, that any Director who is employed by the Company shall be treated as an
Employee under this Plan.

     

    2.13           “Disability” shall mean a
condition whereby the Participant is unable to engage in any substantial gainful
activity by reason of any medically determinable physical impairment which can
be expected to result in death or which is or can be expected to last for a
continuous period of not less than twelve months, all as verified by a physician
acceptable to, or selected by, the Company.

     

    2.14           “Effective Date” shall have
the meaning ascribed to such term in Section 12 hereof.

    

    2.15           “Eligible Persons” means each
officer, Director, Employee, and Consultant to the Company.  An
Employee on leave of absence may be considered as still in the employ of the
Company for purposes of eligibility for participation in the Plan.

     

    2.16           “Employee” means any employee
of the Company.

     

    2.17           “Exchange Act” means the
Securities Exchange Act of 1934, as amended from time to time, or any successor
act thereto.

     

    2.18           “Fair Market Value” as of any
date and in respect of any Share means (i) if the Shares are listed on a
national exchange, the closing price per Share of the Company’s Shares on such
stock exchange on such date, provided at least one sale of Shares took place on
such exchange on such date, and, if not, then on the basis of the closing price
on the last preceding date on which at least one sale on such exchange did
occur, or (ii) if the Shares are not listed on a national exchange, the last
reported sale price per Share in the over-the-counter market on such date, as
reported by the Financial Industry Regulatory Authority’s OTC Bulletin Board,
the National Quotation Bureau Incorporated or any similar organization or agency
reporting prices in the over-the-counter market, or (iii) if the Shares are not
publicly traded, then the value as determined by the Committee in good
faith.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    2.19           “Incentive Stock Option” or
“ISO” means an option to
purchase Shares granted under Section 6 hereof and that is designated as an
Incentive Stock Option and that is intended to meet the requirements
of Code Section 422.

     

    2.20           “Insider” shall mean an
individual who is, on the relevant date, an executive officer, director or
ten percent (10%) beneficial owner of any class of the Company’s equity
securities that is registered pursuant to Section 12 of the Exchange Act,
all as defined under Section 16 of the Exchange Act.

    

    2.21           “Key Employee” shall mean an
individual as defined in Code Section 416(i) (without
regard to paragraph (5) thereof) of the
Company. 

     

    2.22           “Non-Employee Director” shall
mean any Director who is not an employee of the Company or a member of the
immediate family of an employee of the Company.

     

    2.23           “Nonqualified Stock Option” or
“NQSO” means
an option to purchase Shares granted under Section 6 hereof that is
not intended to meet the requirements of Code Section 422, or that
otherwise does not meet such requirements.

     

    2.24           “Option” means an Incentive
Stock Option or a Nonqualified Stock Option.

     

    2.25           “Option Price” means the price
at which a Share may be purchased by a Participant pursuant to an
Option.

     

    2.26           “Participant” means each
Eligible Person who has been selected to receive an Award or who has an
outstanding Award granted under this Plan.

    

    2.27           “Performance Awards” shall
mean any Award of Performance Shares or Performance Units granted pursuant to
Section 8.

    

    2.28           “Performance Period” means
that period established by the Committee at the time any Performance Award is
granted or at any time thereafter during which any performance goals specified
by the Committee with respect to such Award are to be measured.

    

    2.29           “Performance Shares” means any
grant pursuant to Section 8 of a unit valued by reference to a designated number
of Shares, which value may be paid to the Participant by delivery of such
property as the Committee shall determine, including cash, Shares, other
property, or any combination thereof, upon achievement of such performance goals
during the Performance Period as the Committee shall establish at the time of
such grant or thereafter.

    
       

      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    
      

      2.30           “Performance Units” means any
grant pursuant to Section 8 of a unit valued by reference to a designated amount
of property (including cash) other than Shares, which value may be paid to the
Participant by delivery of such property as the Committee shall determine,
including cash, Shares, other property, or any combination thereof, upon
achievement of such performance goals during the Performance Period as the
Committee shall establish at the time of such grant or thereafter.

       

    

    2.31           “Performance-Based Exception”
means the performance-based exception from the tax deductibility limitations of
Code Section 162(m).

     

    2.32           “Period of Restriction” means
the period during which the transfer of Shares of Restricted Stock is limited in
some way (based on the passage of time, the achievement of performance goals, or
upon the occurrence of other events as determined by the Committee, at its
discretion), and the Shares are subject to a substantial risk of forfeiture,
pursuant to the Restricted Stock Award Agreement, as provided in Section 7
hereof.

     

    2.33           “Person” shall have the
meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and
used in Sections 13(d) and 14(d) thereof and the rules promulgated
thereunder, including a “group” as defined in Section 13(d) thereof and the
rules promulgated.

     

    2.34           “Restricted Stock” means a
Stock Award granted to a Participant that is subject to conditions established
by the Board or the Committee as set forth in the Restricted Stock Award
Agreement, which may include, but are not limited to, Continuous Service with
the Company, achievement of specific business objectives and other measurements
of Company performance.

     

    2.35           “Retirement” means termination
of a Participant’s employment with the Company if such termination of employment
constitutes normal retirement, early retirement, disability retirement or other
retirement as provided for at the time of such termination of employment under
the applicable retirement program then maintained by the Company, provided that
the Participant does not continue in the employment of the Company.

     

    2.36           “Securities Act” means the
Securities Act of 1933, as amended from time to time, or any successor act
thereto.

     

    2.37           “Shares” means shares of the
Company’s common stock, par value $0.001 per share.

     

    2.38           “Stock Awards” means a grant
of Restricted Stock or other Shares to a Participant pursuant to Section
7.

     

    2.39           “Ten Percent Shareholder”
means an employee who at the time an ISO is granted owns or is treated as owning
under the applicable Treasury Regulations, Shares possessing more than ten
percent of the total combined voting power of all classes of Shares of the
Company, within the meaning of Code Section 422.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    3.            
ADMINISTRATION

     

    3.1           General.  Subject to
the terms and conditions of this Plan, this Plan shall be administered by the
Committee.  The members of the Committee shall be appointed from time
to time by, and shall serve at the discretion of, the Board of
Directors.  The Committee shall have the authority to delegate
administrative duties to officers of the Company.  For purposes of
making Awards intended to qualify for the Performance Based Exception under Code
Section 162(m), to the extent required under such Code Section, the Committee
shall be comprised solely of two or more individuals who are “outside
directors”, as that term is defined in Code Section 162(m) and the regulations
thereunder. Any award to members of the Committee shall be authorized and
approved by a disinterested majority of the Board.

     

    3.2           Authority of the
Committee.  Except as limited by law or by the Articles of
Incorporation or Bylaws of the Company, and subject to the provisions hereof,
the Committee shall have full power to select Eligible Persons who shall be
offered the opportunity to participate in this Plan; determine the sizes and
types of Awards; determine the terms and conditions of Awards in a manner
consistent with this Plan; construe and interpret this Plan and any agreement or
instrument entered into under this Plan; establish, amend, or waive rules and
regulations for this Plan’s administration; and amend the terms and conditions
of any outstanding Award as provided in this Plan.  Further, the
Committee shall make all other determinations that it deems necessary or
advisable for the administration of this Plan.  As permitted by law
and the terms of this Plan, the Committee may delegate its authority herein to
officers of the Company.  No member of the Committee shall be liable
for any action taken or decision made in good faith relating to this Plan or any
Award granted hereunder.

     

    3.3           Decisions
Binding.  All determinations and decisions made by the
Committee pursuant to the provisions of this Plan and all related orders and
resolutions of the Committee shall be final, conclusive, and binding on all
persons, including the Company, its shareholders, Directors, Employees,
Participants, and their estates and beneficiaries, unless changed by the
Board.

     

    4.            
SHARES SUBJECT TO THIS PLAN

     

    4.1           Number of Shares Available for
Grants.  Subject to adjustment as provided in Section 4.2
hereof, the number of Shares hereby reserved for issuance to Participants under
this Plan shall five million shares (5,000,000).  Any Shares covered
by an Award (or portion of an Award) granted under this Plan which is forfeited
or canceled or expires shall be deemed not to have been delivered for purposes
of determining the maximum number of Shares available for delivery under this
Plan.  Shares may be authorized, unissued shares or Treasury
shares.  The Committee shall determine the appropriate methodology for
calculating the number of Shares issued pursuant to this
Plan.  

     

    4.2           Adjustments in Authorized
Shares.  Upon a change in corporate capitalization, such as a
stock split, stock dividend or a corporate transaction, such as any merger,
consolidation, combination, exchange of shares or the like, separation,
including a spin-off, or other distribution of stock or property of the Company,
any reorganization (whether or not such reorganization comes within the
definition of such term in Code Section 368) or any partial or complete
liquidation of the Company, a proportionate adjustment shall be made in: (i) the
number and class of Shares reserved for issuance to Participants under the Plan,
and (ii) the number and class of and/or price of Shares subject to outstanding
Awards granted under the Plan, in such manner as may be determined to be
appropriate and equitable by the Committee, in its sole discretion, to prevent
dilution or enlargement of rights.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    4.3           Adjustment of Awards Upon the
Occurrence of Certain Unusual or Nonrecurring Events.  The
Committee may make adjustments in the terms and conditions of, and the criteria
included in, Awards in recognition of unusual or nonrecurring events (including,
without limitation, the events described in Section 4.2 hereof) affecting the
Company or the financial statements of the Company or of changes in applicable
laws, regulations, or accounting principles, whenever the Committee determines
that such adjustments are appropriate in order to prevent dilution or
enlargement of the benefits or potential benefits intended to be made available
under this Plan; provided that, unless the Committee determines otherwise at the
time such adjustment is considered, no such adjustment shall be authorized to
the extent that such authority would be inconsistent with this Plan’s or any
Award’s meeting the requirements of Section 162(m) of the Code, as from time to
time in effect.

     

    5.            
ELIGIBILITY AND PARTICIPATION

     

    5.1           Eligibility.  Awards
may be granted under the Plan only to Eligible Persons.

    

    5.2           Actual
Participation.  Subject to the provisions of this Plan, the
Committee may, from time to time, select from all Eligible Persons, those to
whom Awards shall be granted and shall determine the nature and amount of each
Award, provided that only Employees of the Company, shall be Eligible Persons
for purposes of receiving any Incentive Stock Options.

     

    6.            
STOCK OPTIONS

     

    6.1           Grant of Options. Subject to
the terms and provisions of this Plan, Options may be granted to Participants in
such number, and upon such terms, and at any time and from time to time as
shall be determined by the Committee.

     

    6.2           Award Agreement. Each Option
grant shall be evidenced by an Option Award Agreement that shall specify the
Option Price, the duration of the Option, the number of Shares to which the
Option pertains, and such other provisions as the Committee shall determine
which are not inconsistent with the terms of this Plan.

     

    6.3           Option Price. The Option Price
for each grant of an Option under this Plan shall be as determined by the
Committee; provided, however, the per-share exercise price shall not, in any
event, be less than the par value of a Share on the date of the grant of the
Option.  The Option Price for each ISO shall equal the Fair Market
Value of the Shares at the time such option is granted.  If an ISO is
granted to a Ten Percent Shareholder the Option Price shall be at least 110
percent of the Fair Market Value of the stock subject to the ISO.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    6.4           Duration of Options. Except as
otherwise provided in this Plan, each Option granted to a Participant shall
expire at such time as the Committee shall determine at the time of grant,
provided that an ISO must expire no later than the tenth (10th) anniversary of
the date the ISO was granted.  However, in the case of an ISO granted
to a Ten Percent Shareholder, the ISO by its terms shall not be exercisable
after the expiration of five (5) years from the date such ISO is
granted.

     

    6.5           Exercise of Options. Options
shall be exercisable at such times and be subject to such restrictions and
conditions as the Committee shall in each instance approve, which need not be
the same for each grant or for each Participant.

     

    6.6           Payment. Options shall be
exercised by the delivery of a written notice of exercise to the Company or its
designated agent, setting forth the number of Shares with respect to which the
Option is to be exercised, accompanied by full payment of the Option Price for
the Shares.

     

    Upon the
exercise of any Option, the Option Price for the Shares being purchased pursuant
to the Option shall be payable to the Company in full either: (a) in cash
or its equivalent; or (b) subject to the
Committee’s approval, by delivery of previously acquired Shares having an
aggregate Fair Market Value at the time of exercise equal to the total Option
Price (provided that the Shares that are delivered must have been held by the
Participant for at least six (6) months prior to their delivery to satisfy the
Option Price); or (c) by a combination of (a) and (b); or (d) by any
other method approved by the Committee in its sole discretion.  Unless
otherwise determined by the Committee, the delivery of previously acquired
Shares may be done through attestation.  No fractional shares may be
tendered or accepted in payment of the Option Price.

     

    Unless
otherwise determined by the Committee, cashless exercises are permitted pursuant
to Federal Reserve Board’s Regulation T, subject to applicable securities
law restrictions, or by any other means which the Committee determines to be
consistent with this Plan’s purpose and applicable law.

     

    Subject
to any governing rules or regulations, as soon as practicable after receipt of
notification of exercise and full payment, the Company shall deliver to the
Participant, in the Participant’s name, Share certificates in an appropriate
amount based upon the number of Shares purchased pursuant to the
Option(s).

     

    Unless
otherwise determined by the Committee, all payments under all of the methods
indicated above shall be paid in United States dollars.

     

    6.7           Restrictions on Share
Transferability.  The Committee may impose such restrictions on
any Shares acquired pursuant to the exercise of an Option granted under this
Section 6 as it may deem advisable, including, without limitation, restrictions
under applicable federal securities laws, under the requirements of any stock
exchange or market upon which such Shares are then listed and/or traded, or
under any blue sky or state securities laws applicable to such
Shares.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    6.8           Nontransferability of
Options.

    

    (a)           Incentive Stock Options. No
ISO granted under this Plan may be sold, transferred, pledged, assigned,
encumbered or otherwise alienated or hypothecated, other than by will or by the
laws of descent and distribution.  Further, all ISOs granted to a
Participant under this Plan shall be exercisable during such Participant’s
lifetime only by such Participant.

    

    (b)           Nonqualified Stock Options.
Except as otherwise provided in the applicable Award Agreement, no NQSO may be
sold, transferred, pledged, assigned, encumbered or otherwise alienated or
hypothecated, other than by will or by the laws of descent and
distribution.  Further, except as otherwise provided in the applicable
Award Agreement, all NQSOs granted to a Participant shall be exercisable during
such Participant’s lifetime only by such Participant.

     

    6.9           Special Limitation on Grants of
Incentive Stock Options. No ISO shall be granted to an Employee under
this Plan or any other ISO plan of the Company to purchase Shares as to which
the aggregate Fair Market Value (determined as of the date the ISO is granted)
of the Shares which first become exercisable by the Employee in any calendar
year exceeds $100,000.  To the extent an Option initially designated
as an ISO exceeds the value limit of this Section 6.9 or otherwise fails to
satisfy the requirements applicable to ISOs, it shall be deemed a NQSO and shall
otherwise remain in full force and effect.

      

    7.            
STOCK AWARDS

     

    7.1           Grant of Stock Awards. Subject
to the terms and provisions of this Plan, the Committee, at any time and from
time to time, may grant Stock Awards to Participants in such amounts as the
Committee shall determine. All or any part of any Stock Award may, but need not
be, Restricted Stock.

     

    7.2           Award Agreement. Each
Restricted Stock grant shall be evidenced by a Restricted Stock Award Agreement
that shall specify the Period(s) of Restriction, the number of Shares of
Restricted Stock granted, and such other provisions as the Committee shall
determine which are not inconsistent with the terms of this Plan.

     

    7.3           Transferability. Except as
provided in the Award Agreement, the Shares of Restricted Stock granted herein
may not be sold, transferred, pledged, assigned, encumbered, or otherwise
alienated or hypothecated until the end of the applicable Period of Restriction
established by the Committee and specified in the Restricted Stock Award
Agreement, or upon earlier satisfaction of any other conditions, as specified by
the Committee in its sole discretion and set forth in the Restricted Stock Award
Agreement.  All rights with respect to the Restricted Stock granted to
a Participant under this Plan shall be available during such Participant’s
lifetime and prior to the end of the Period of Restriction only to such
Participant.

     

    7.4           Other Restrictions. The
Committee may impose such other conditions and/or restrictions on any Shares of
Restricted Stock granted pursuant to this Plan as it may deem advisable
including, without limitation, a requirement that Participants pay a stipulated
purchase price for each Share of Restricted Stock, restrictions based upon the
achievement of specific performance goals, time-based restrictions on vesting
following the attainment of the performance goals, time-based restrictions,
and/or restrictions under applicable federal or state securities
laws.

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    
 

    Restricted
Stock granted under the Plan may be evidenced in such manner as the Committee
shall determine.  If certificates representing Restricted Stock are
registered in the name of the Participant, the Committee may require that such
certificates bear an appropriate legend referring to the terms, conditions and
restrictions applicable to such Restricted Stock, that the Company retain
physical possession of the certificates until such time as all conditions and/or
restrictions applicable to such Restricted Stock have been satisfied, and that
the Participant deliver a stock power to the Company, endorsed in blank,
relating to the Restricted Stock.

     

    Except as
otherwise provided in the Award Agreement, Shares of Restricted Stock covered by
each Restricted Stock grant made under this Plan shall become freely
transferable by the Participant after the last day of the applicable Period of
Restriction.

     

    7.5              Voting Rights. If the
Committee so determines, Participants holding Shares of Restricted Stock granted
hereunder may be granted the right to exercise full voting rights with respect
to those Shares during the Period of Restriction.

     

    7.6              Dividends and Other
Distributions. During the Period of Restriction, Participants holding
Shares of Restricted Stock granted hereunder (whether or not the Company holds
the certificate(s) representing such Shares) may, if the Committee so
determines, be credited with dividends paid with respect to the underlying
Shares while they are so held.  The Committee may apply any
restrictions to the dividends that the Committee deems appropriate. Without
limiting the generality of the preceding sentence, if the grant or vesting of
Restricted Shares granted to a Covered Employee is designed to comply with
the requirements of the Performance-Based Exception, the Committee may apply any
restrictions it deems appropriate to the payment of dividends declared with
respect to such Restricted Stock, such that the dividends and/or the Restricted
Stock maintain eligibility for the Performance-Based Exception.

    

    8.            
PERFORMANCE AWARDS AND PERFORMANCE MEASURES

    

    8.1           Grant of Performance Awards.
Subject to the terms of the Plan, Performance Units and/or Performance
Shares Awards may be granted to Participants in such amounts and upon such
terms, and at any time and from time to time, as shall be determined by the
Committee.

    

    8.2           Award Agreement. At the
Committee’s discretion, each grant of Performance Units and/or Performance
Shares Awards may be evidenced by a Performance Award Agreement that shall
specify the initial value, the duration of the Award, the performance measures,
if any, applicable to the Award, and such other provisions as the Committee
shall determine which are not inconsistent with the terms of the
Plan.

    

    8.3           Value of Performance Awards.
Each Performance Units and/or Performance Shares Award shall have an
initial value that is established by the Committee at the time of
grant.  Each Performance Share shall have an initial value equal to
the Fair Market Value of a Share on the date of grant.  The Committee
shall set performance goals in its discretion which, depending on the extent to
which they are met, will determine the number and/or value of Performance Awards
that will be paid out to the Participant.  For purposes of this
Section 8, the time period during which the performance goals must be met shall
be the “Performance
Period” as described below in Section 8.8.

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

    8.4           Earning of Performance Units/Shares
Awards.  Subject to the terms of this Plan, after the
applicable Performance Period has ended, the holder of Performance Units and/or
Performance Shares Awards shall be entitled to receive a payout based on the
number and value of Performance Units and/or Performance Shares Awards earned by
the Participant over the Performance Period, to be determined as a function of
the extent to which the corresponding performance goals have been
achieved.

    

    8.5           Form and Timing of Payment of
Performance Awards.  Payment of earned Performance Awards shall
be as determined by the Committee and, if applicable, as evidenced in the
related Award Agreement.  Subject to the terms of the Plan,
the Committee, in its sole discretion, may pay earned Performance
Units/Shares Awards in the form of cash or in Shares (or in a combination
thereof) that have an aggregate Fair Market Value equal to the value of the
earned Performance Units/Shares Awards at the close of the applicable
Performance Period. Such Shares may be delivered subject to any restrictions
deemed appropriate by the Committee. No fractional shares will be
issued.  No Participant shall receive any payment under the Plan that
is subject to this Section 8 unless the Committee has certified, by
resolution or other appropriate action in writing, that the performance criteria
and any other material terms previously established by the Committee or set
forth in the Plan, have been satisfied to the extent necessary to qualify as
"performance based compensation" under Code Section 162(m).  The
determination of the Committee with respect to the form of payout of such Awards
shall be set forth in the Award Agreement pertaining to the grant of the Award
or the resolutions establishing the Award.  Unless otherwise provided
by the Committee, Participants holding Performance Units and/or Performance
Shares shall be entitled to receive dividend units with respect to dividends
declared with respect to the Shares represented by such Performance Units and/or
Performance Shares.  Such dividends may be subject to the same
accrual, forfeiture, and payout restrictions as apply to dividends earned with
respect to Shares of Restricted Stock, as set forth in Section 7.6 hereof, as
determined by the Committee.

    

    8.6           Nontransferability.  Except
as otherwise provided in a Participant’s Award Agreement, Performance Units
and/or Performance Shares Awards may not be sold, transferred, pledged,
assigned, encumbered, or otherwise alienated or hypothecated, other than by will
or by the laws of descent and distribution.

    

    8.7           Performance
Criteria.  If a Performance Award is designed to qualify for
the Performance-Based Exception and subject to this Section 8, then the lapsing
of restrictions thereon and the distribution of cash, Shares or other property
pursuant thereto, as applicable, shall be contingent upon achievement of one or
more objective performance goals.  Performance goals shall be
objective and shall otherwise meet the requirements of Section 162(m) of the
Code and regulations thereunder including the requirement that the level or
levels of performance targeted by the Committee result in the achievement of
performance goals being “substantially uncertain.”  One or more of the
following performance measures for the Company shall be used by the Committee in
establishing performance goals for such Awards:

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

     

    (a)           Earnings
per share;

     

    (b)           Net
income (before or after taxes);

     

    (c)           Cash
flow (including, but not limited to, operating cash flow and free cash
flow);

     

    (d)           Gross
revenues;

     

    (e)           Gross
margins;

     

    (f)           
EBITDA;

     

    (g)           Any
of the above measures compared to peer or other companies;

     

    (h)           Scientific
milestones and objectives;

    

    (i)           Cost
containment goals; and

     

    (j)           Achievement
of other business objectives

     

    Performance
measures may be set either at the corporate level, subsidiary level, division
level, or business unit level.  The Committee shall exclude the impact
of an event or occurrence which the Committee determines should appropriately be
excluded, including without limitation (i) restructurings, discontinued
operations, extraordinary items, and other unusual or non-recurring charges,
(ii) an event either not directly related to the operations of the Company or
not within the reasonable control of the Company’s management, or (iii) a change
in accounting standards required by generally accepted accounting
principles.  If applicable tax and/or securities laws change to permit
Committee discretion to alter the governing performance measures without
obtaining shareholder approval of such changes, the Committee shall have sole
discretion to make such changes without obtaining shareholder
approval.

     

    8.8           Performance Period; Timing For
Establishing Performance Goals.
Achievement of performance goals in respect of Performance Awards shall be
measured over a Performance Period no shorter than twelve (12) months and no
longer than five (5) years, as specified by the
Committee.  Performance goals shall be established not later than 90
days after the beginning of any Performance Period applicable to such
Performance Awards, or at such other date as may be required or permitted for
“performance-based compensation” under Code Section 162(m).

     

    8.9           Adjustments.  The
Committee may, in its discretion, reduce the amount of a settlement otherwise to
be made in connection with Awards subject to this Section 8, but may not
exercise discretion to increase any such amount payable to a Covered Employee in
respect of an Award subject to this Section 8.  The Committee shall
specify the circumstances in which such Awards shall be paid or forfeited in the
event of termination of Continuous Service by the Participant prior to the end
of a Performance Period or settlement of Awards.

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    9.            
RIGHTS OF PARTICIPANTS

     

    9.1           Employment. Nothing in this
Plan shall confer upon any Participant any right to continue as an Employee,
Director or Consultant or in applicable Award Agreement consistent with Sections
6.2, 7.2 or 8.2, and a Participant shall have none of the rights of a
shareholder with respect to shares of Common Stock covered by any Award until
the Participant becomes the record holder of such Shares, or the Period of
Restriction has expired, as applicable.

    

    9.2       Participation. No Eligible
Person shall have the right to be selected to receive an Award under this Plan,
or, having been so selected, to be selected to receive a future
Award.

    

    9.3       Rights as a Shareholder.
Except as provided in Sections 7.5, 7.6 and 8.5 or in applicable Award Agreement
consistent with such Sections, a Participant shall have none of the rights of a
shareholder with respect to shares of Common Stock covered by any Award until
the Participant becomes the record holder of such Shares, or the Period of
Restriction has expired, as applicable.

    

    10.           TERMINATION
OF EMPLOYMENT/DIRECTORSHIP/CONSULTANCY

     

    10.1           Termination of Service. Upon
termination of the Participant’s employment, directorship or provision of
services to the Company for any reason other than Retirement, Disability or
death, an Award granted to the Participant may be exercised by the Participant
or permitted transferee at any time on or prior to the earlier of the expiration
date of the Award or the expiration of three (3) months after the date of
termination but only if, and to the extent that, the Participant was entitled to
exercise the Award at the date of termination.  All Awards or any
portion thereof not yet vested or exercisable or whose Period of Restriction has
not expired as of the date of termination (other than a termination by reason of
Retirement, Disability or death) shall terminate and be forfeited immediately on
the date of termination.  If the employment or directorship of a
Participant terminates by reason of the Participant’s Retirement, Disability or
death, all Awards or any portion thereof not yet vested or exercisable or whose
Period of Restriction has not expired as of the date of a Participant’s
Disability or death shall terminate and be forfeited immediately on the date of
termination.  If the employment or directorship of a Participant
terminates by reason of the Participant’s Retirement, Disability or death, the
Participant (or, if appropriate, the Participant’s legal representative or
permitted transferee) may exercise such Participant’s rights under any
outstanding Award at any time on or prior to the original expiration date of the
Award; provided, however, that if an Award is an ISO, the Participant (or, if
appropriate, the Participant’s legal representative or permitted transferee) may
exercise such Participant’s rights under any outstanding Award at any time on or
prior to the earlier of (i) the original expiration date of the Award or (ii)
(A) in the case of Retirement, the expiration of three (3) months after the date
of termination or (B) in the case of Disability or death, the first anniversary
of the date of termination.

     

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

    

     

    For
purposes of this Section, a “termination” includes an event which causes a
Participant to lose his eligibility to participate in this Plan.  In
the case of a Consultant, the meaning of “termination” or “termination of
employment” includes the date that the individual ceases to provide services to
the Company.  In the case of a Non-Employee Director, the meaning of
“termination” includes the date that the individual ceases to be a director of
the Company.

     

    Notwithstanding
the foregoing, the Committee has the authority to prescribe different rules that
apply upon the termination of a particular Participant’s service as an Employee,
Director or Consultant, which shall be memorialized in the Participant’s
original or amended Award Agreement or similar document.

    

    10.2           Leave of
Absence.  Unless otherwise determined by the Committee, an
authorized leave of absence pursuant to a written agreement or other leave
entitling an Employee to reemployment in a comparable position by law or rule
shall not constitute a termination of employment for purposes of this Plan
unless the Employee does not return at or before the end of the authorized leave
or within the period for which re-employment is guaranteed by law or
rule.

     

    10.3           Unexercised
Awards.  An Award that remains unexercised after the latest
date it could have been exercised under any of the foregoing provisions or under
the terms of the Award shall be forfeited.

     

    11.           CHANGE
IN CONTROL

     

    In the
event of a Change in Control, unless otherwise specifically prohibited under
applicable laws, or by the rules and regulations of any governing governmental
agencies or national securities exchange or trading system, or unless the
Committee shall otherwise specify in the Award Agreement, the Board, in its sole
discretion, may:

     

    (a)           elect
to terminate Options in exchange for a cash payment equal to the amount by which
the Fair Market Value of the Shares subject to such Option to the extent the
Option has vested exceeds the exercise price with respect to such
Shares;

    

    (b)           elect
to terminate Options provided that each Participant is first notified of and
given the opportunity to exercise his/her vested Options for a specified period
of time (of not less than 15 days) from the date of notification and before the
Option is terminated;

     

    (c)           permit
Awards to be assumed by a new parent corporation or a successor corporation (or
its parent) and replaced with a comparable Award of the parent corporation or
successor corporation (or its parent);

     

    (d)           amend
an Award Agreement or take such other action with respect to an Award that it
deems appropriate; or

     

    (e)           implement
any combination of the foregoing.

     

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

    

     

    12.          PLAN
EFFECTIVE DATE, AMENDMENT, MODIFICATION, AND
TERMINATION

     

    12.1           Plan Effective Date and Shareholder
Approval.  The Plan’s effective date shall be the date on which
the Plan is adopted and approved by the Board (the “Effective Date”) so long as
within twelve (12) months of its adoption and approval by the Board, the Plan is
approved by the shareholders of the Company eligible to vote in the election of
directors, by a vote sufficient to meet the requirements of Code Sections 162(m)
(if applicable) and 422, Rule 16b-3 under the Exchange Act (if applicable),
applicable requirements under the rules of any stock exchange or automated
quotation system on which the Shares may be listed or quoted, and other laws,
regulations, and obligations of the Company applicable to the Plan. If the
Company fails to obtain shareholder approval of the Plan within twelve (12)
months after the date this Plan is adopted by the Board, pursuant to Section 422
of the Code, any Option granted as an ISO at any time under the Plan will not
qualify as an ISO within the meaning of the Code and will be deemed to be a
NQSO.

    

    12.2           Amendment, Modification, and
Termination. The Board may amend, alter, suspend, discontinue or
terminate the Plan, or the Committee's authority to grant Awards under the Plan,
without the consent of shareholders or Participants, except that any amendment
or alteration to the Plan shall be subject to the approval of the Company's
shareholders not later than the annual meeting next following such Board action
if such shareholder approval is required by any federal or state law or
regulation (including, without limitation, Rule 16b-3 or Code Section 162(m)) or
the rules of any stock exchange or automated quotation system on which the
Shares may then be listed or quoted, and the Board may otherwise, in its
discretion, determine to submit other such changes to the Plan to shareholders
for approval; provided that, without the consent of an affected Participant, no
such Board action may materially and adversely affect the rights of such
Participant under any previously granted and outstanding Award.  The
Board may waive any conditions or rights under, or amend, alter, suspend,
discontinue or terminate any Award theretofore granted and any Award Agreement
relating thereto, except as otherwise provided in the Plan; provided that,
without the consent of an affected Participant, no such Board action may
materially and adversely affect the rights of such Participant under such
Award.  Notwithstanding anything to the contrary, the Board shall be
authorized to amend any outstanding Option to reduce the exercise price or grant
price without the prior approval of the shareholders of the
Company.  In addition, the Board shall be authorized to cancel
outstanding Options and to replace with Awards having a lower exercise price
without the prior approval of the shareholders of the Company.

     

    13.           WITHHOLDING

     

    The
Company shall have the power and the right to deduct or withhold, or require a
Participant to remit to the Company, an amount sufficient to satisfy any
applicable taxes (including social security or social charges), domestic or
foreign, required by law or regulation to be withheld with respect to any
taxable event arising as a result of this Plan.  The Participant may
satisfy, totally or in part, such Participant’s obligations pursuant to this
Section 13 by electing to have Shares withheld, to redeliver Shares acquired
under an Award, or to deliver previously owned Shares that have been held for at
least six (6) months, provided that the election is made in writing on or prior
to (i) the date of exercise, in the case of Options, and (ii) the expiration of
the Period of Restriction in the case of Restricted Stock.  Any
election made under this Section 13 may be disapproved by the Committee at any
time in its sole discretion.  If an election is disapproved by the
Committee, the Participant must satisfy his obligations pursuant to this
paragraph in cash.

     

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

     

    14.           SUCCESSORS

     

    All
obligations of the Company under this Plan with respect to Awards granted
hereunder shall be binding on any successor to the Company, whether the
existence of such successor is the result of a direct or indirect purchase,
through merger, consolidation, or otherwise, of all or substantially all of the
business, stock and/or assets of the Company.

     

    15.           GENERAL
PROVISIONS

     

    15.1           Gender and
Number.  Except where otherwise indicated by the context, any
masculine term used herein also shall include the feminine; the plural shall
include the singular and the singular shall include the plural.

     

    15.2           Severability.  If
any provision of this Plan shall be held illegal or invalid for any reason, the
illegality or invalidity shall not affect the remaining parts of this Plan, and
this Plan shall be construed and enforced as if the illegal or invalid provision
had not been included.

     

    15.3           Requirements of Law. The
granting of Awards and the issuance of Shares under this Plan shall be subject
to all applicable laws, rules, and regulations, and to such approvals by any
governmental agencies or national securities exchanges as may be
required.

     

    15.4           Securities Law Compliance.
With respect to Insiders, transactions under this Plan are intended to comply
with all applicable conditions of Rule 16b-3 or its successors under the
Exchange Act, unless determined otherwise by the Board.  To the extent
any provision of this Plan or action by the Committee fails to so comply, it
shall be deemed null and void, to the extent permitted by law and deemed
advisable by the Board.

     

    15.5           Registration. The Company
shall use reasonable endeavors to register Shares issued pursuant to Awards
under the Securities Act on Form S-8 or other suitable Form and to effect
compliance with the registration, qualification, and listing requirements of any
state or foreign securities laws, stock exchange, or trading
system.

     

    15.6           Inability to Obtain Authority.
The inability of the Company to obtain authority from any regulatory body having
jurisdiction, which authority is deemed by the Company’s counsel to be necessary
to the lawful issuance and sale of any Shares hereunder, shall relieve the
Company of any liability in respect of the failure to issue or sell such Shares
as to which such requisite authority shall not have been obtained.

     

    15.7           No Additional Rights. Neither
the Award nor any benefits arising under this Plan shall constitute part of an
employment contract between the Participant and the Company, and accordingly,
subject to Section 12.2, this Plan and the benefits hereunder may be
terminated at any time in the sole and exclusive discretion of the Committee
without giving rise to liability on the part of the Company for severance
payments.

     

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

     

    15.8           Noncertificated Shares. To the
extent that this Plan provides for issuance of certificates to reflect the
transfer of Shares, the transfer of such Shares may be effected on a
noncertificated basis, to the extent not prohibited by applicable law or the
rules of any stock exchange or trading system.

    

    15.9           Payments in the Event of Forfeitures;
Fractional Shares.  Unless otherwise determined by the
Committee, in the event of a forfeiture of an Award with respect to which a
Participant paid cash or other consideration, the Participant shall be repaid
the amount of such cash or other consideration.  No fractional Shares
shall be issued or delivered pursuant to the Plan or any Award.  The
Committee shall determine whether cash, other Awards or other property shall be
issued or paid in lieu of such fractional shares or whether such fractional
shares or any rights thereto shall be forfeited or otherwise
eliminated.

     

    15.10                      Governing Law; Participants in
Foreign Countries. This Plan and each Award Agreement shall be governed
by the laws of Nevada, excluding any conflicts or choice of law rule or
principle that might otherwise refer construction or interpretation of this Plan
to the substantive law of another jurisdiction.  Unless otherwise
provided in the Award Agreement, recipients of an Award under this Plan are
deemed to submit to the exclusive jurisdiction and venue of the federal or state
courts whose jurisdiction covers Los Angeles, California, to resolve any and all
issues that may arise out of or relate to this Plan or any related Award
Agreement.  The Committee shall have the authority to adopt such
modifications, procedures, and subplans as may be necessary or desirable to
comply with provisions of the laws of foreign countries in which the Company may
operate to assure the viability of the benefits from Awards granted to
Participants performing services in such countries and to meet the objectives of
the Plan.

    

    15.11                      Compliance with Code Section
409A. No Award that is subject to Section 409A of the Code shall provide
for deferral of compensation that does not comply with Section 409A of the Code,
unless the Board, at the time of grant, specifically provides that the Award is
not intended to comply with Section 409A of the Code.  Notwithstanding
any provision in this Plan to the contrary, with respect to any Award subject to
Section 409A, distributions on account of a separation from service may not be
made to Key Employees before the date which is six (6) months after the date of
separation from service (or, if earlier, the date of death of the
employee).

    

    

    * * * *
*

     

     

    17ex10-1.htm

     

    
      

      

    

    
      ASSET
PURCHASE AGREEMENT

       

      THIS AGREEMENT (together with
the exhibits and schedules attached hereto, this “Agreement”) dated as of April
15, 2009.

       

      BETWEEN:

       

      PHOINOS OXFORD LIFESCIENCES LIMITED,
a company incorporated under the laws of the Federation of St. Kitts
& Nevis and having a registered address c/o Global Corporate and Trust
Management Ltd., PO Box 555 Hunkins Plaza, Main Street, Charlestown, Nevis, West
Indies.

      

      (herein
called the “Seller”)

       

      AND:

       

      KINDER TRAVEL INC., a company
incorporated under the laws of the State of Nevada and having a registered
address at 20385 64 Avenue,
Langley, BC CANADA V2Y 1N5

       

      (herein
called the “Purchaser”)

       

      WHEREAS,
the Purchaser desires to purchase and acquire from the Seller and the Seller
desires to sell and assign to the Purchaser all of the Seller’s rights, title
and interest in three (3) medical patents as set forth in Schedule A attached
hereto (the “Patents”);
and

       

      WHEREAS,
the parties desire to enter into this Agreement to set forth their mutual
agreements concerning the above matter;

       

      NOW,
THEREFORE, in consideration of the mutual promises of the parties hereto, and of
good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, it is mutually agreed by and between the parties hereto as
follows:

       

      ARTICLE
1

       

      SALE
AND TRANSFER OF PATENTS

       

      1.1 Sale of Patents.
Subject to the terms and conditions of this Agreement and in reliance upon the
representations, warranties, covenants and agreements contained herein, at the
closing of the transactions contemplated hereby, the Seller will sell, convey,
assign and transfer the Patents to the Purchaser, and the Purchaser will
purchase and acquire the Patents from the Seller.

       

      1.2 Consideration.  In
consideration of the sale, transfer and assignment to the Purchaser of the
Patents, the Purchaser shall, at Closing, issue in the name of the Seller or in
such other name as the Seller may otherwise direct, an aggregate of two hundred
and fifty thousand shares of common stock of the Purchaser on a fully diluted
basis (the "Shares")
which equals approximately seventy-five thousand US dollars (USD 75,000) based
on the last closing price of the Shares of $0.30 per share as reported by the
OTC Bulletin Board on October 8, 2008 (hereinafter referred to as the “Purchase Price”).

       

      1.3         Escrow Agreement. The
Shares as described in Section 1.2 shall be subject to an Escrow Agreement which
is attached as Schedule B hereto. The Shares will be released to the Seller in
accordance with the terms of the Escrow Agreement.

       

      1.4 The
Closing.  The transfer and delivery of the documents
transferring the Patents to the Purchaser and the Shares to the Escrow Agent (as
defined in Schedule B hereto) and the exchange and delivery by the parties of
the other documents and instruments contemplated by this Agreement, (the “Closing”) will take place on
April 30, 2009 or such earlier date as may be mutually acceptable to the Seller
and the Purchaser, subject to the satisfaction or waiver (by the party receiving
the benefit thereof) of the conditions precedent set forth in Section 6 of this
Agreement (the “Closing
Date”).

       

      
        
           

        

        
          1

          
            

          

        

        
           

        

      

      1.5 Deliveries.  At
the Closing on the Closing Date:

       

      
        	
                (a)  

              	
                The
      Purchaser shall deliver or cause to be delivered to the Escrow Agent a
      certificate issued in the name of the Seller, or in such other name as the
      Seller may otherwise direct, evidencing the
  Shares.

              

      

       

      
        	
                (b)  

              	
                The
      Seller shall deliver to the Purchaser executed and duly acknowledged
      assignments conveying all right, title and interest of the Seller to the
      Patents to the Purchaser.

              

      

       

      
        	
                (c)  

              	
                The
      Seller and the Purchaser shall each execute and deliver such other
      instruments and take such other action as may be necessary to carry out
      its obligations under this Agreement; including, without limitation,
      working together to cause the title to any assets to be transferred into
      the name of the Purchaser in the applicable governmental
      records.

              

      

       

      1.6 Expenses of
Seller.  Any liability or obligation of the Seller arising or
incurred in connection with the negotiation, preparation and execution of this
Agreement and the transactions contemplated hereby and any fees and expenses of
counsel, accountants and other experts employed by Seller shall be paid by the
Purchaser.

       

      ARTICLE
2

       

      TITLE
DUE DILIGENCE

       

      2.1 Access to
Patents.  The Seller shall grant the Purchaser such access to
the Patents, including all records relating to same, as is necessary to permit
the Purchaser to conduct a thorough due diligence investigation of the title to
the Patents.  The Purchaser shall have a maximum of fifteen (15) days
from the date of this Agreement to conduct its due diligence (this 15-day
period, as it may be extended in accordance with this Agreement or by other
agreement of the parties, will be referred to herein as the “Due Diligence
Period”).

       

      2.2 The
Purchaser shall notify the Seller in writing (the “Defect Notice”) by the end of
the Due Diligence Period of any failures or defects in title (“Title Defects”) that the
Purchaser may have identified as pertaining to the Patents.  The
Defect Notice shall identify the alleged defect and the nature of the
defect.  If no defects are identified in said written notice, the
Purchaser will be deemed to have accepted title for said
Patents.  Upon receipt of Defect Notice, the Seller shall have until
the Closing to cure any such Title Defects or, if not curable prior to the
Closing, advise the Purchaser how such Title Defects will be cured following the
Closing and provide a satisfactory commitment to the Purchaser with respect to
curing of such Title Defects. If the Seller is unable to cure any material Title
Defects to the Purchaser’s reasonable satisfaction or provide a plan and
commitment to cure such Title Defects prior to the Closing, then the Purchaser
may (i) terminate this Agreement; or (ii) proceed with the Closing with no
reduction in the Purchase Price.  Title Defect, as used in this
Agreement, shall mean any lien, encumbrance, encroachment or other defect in the
Seller’s title to the Patents that would cause the Seller not to have defensible
title to such Patents.

       

      
        
           

        

        
          2

          
            

          

        

        
           

        

      

      ARTICLE
3

       

      REPRESENTATIONS
AND WARRANTIES OF THE SELLER

       

      To induce
the Purchaser to execute, deliver and perform this Agreement, and in
acknowledgement of the Purchaser’s reliance on the following representations and
warranties, the Seller represents and warrants to the Purchaser as follows as of
the date hereof and as of the Closing Date:

       

      3.1 Organization.  The
Seller is a corporation duly organized, validly existing and in good standing
under the applicable laws of the Federation of St. Kitts and Nevis, with the
power and authority to conduct its business as it is now being conducted and to
own its assets.

       

      3.2 Power and
Authority.  The Seller has the power and authority to execute,
deliver, and perform this Agreement and the other agreements and instruments to
be executed and delivered by them in connection with the transactions
contemplated hereby, and the Seller will have taken all necessary action to
authorize the execution and delivery of this Agreement and such other agreements
and instruments and the consummation of the transactions contemplated hereby,
including but not limited to the receipt of all necessary regulatory
approvals.  The execution, delivery and performance by the Seller of
the Agreement has been duly authorized. This Agreement is, and the other
agreements and instruments to be executed and delivered by the Seller in
connection with the transactions contemplated hereby, when such other agreements
and instruments are executed and delivered, shall be, the valid and legally
binding obligations of the Seller enforceable against the Seller in accordance
with their respective terms.

       

      3.3 Non-Contravention. To
the Seller’s knowledge, neither the execution, delivery and/or performance of
this Agreement, nor the consummation of the transactions contemplated hereby,
will:

       

              (a)            conflict
with, result in a violation of, cause a default under (with or without notice,
lapse of time or both) or give rise to a right of termination, amendment,
cancellation or acceleration of any obligation contained in or the loss of any
material benefit under, or result in the creation of any lien, security
interest, charge or encumbrance upon any of the material properties or assets of
Seller under any term, condition or provision of any loan or credit agreement,
note, debenture, bond, mortgage, indenture, lease or other agreement,
instrument, permit, license, judgment, order, decree, statute, law, ordinance,
rule or regulation applicable to Seller, or any of its material property or
assets;

          

              (b)           violate
any provision of the articles or bylaws of Seller; or

       

              (c)           violate
any order, writ, injunction, decree, statute, rule, or regulation of any court
or governmental or regulatory authority in the Netherlands Antilles that would
result in a Seller Material Adverse Effect (defined below).

       

      3.4 Actions and
Proceedings. To the knowledge of Seller, (i) there is no basis for and
there is no action, suit, judgment, claim, demand or proceeding outstanding or
pending, or threatened against or affecting Seller or which involves any of the
business, or the properties or assets of Seller that, if adversely resolved or
determined, would have a material adverse effect on the Patents (a “Seller Material Adverse
Effect”), and
(ii) there is no reasonable basis for any claim or action that, based upon the
likelihood of its being asserted and its success if asserted, would have such a
Seller Material Adverse Effect.

       

      3.5 Compliance. 

       

              (a)           To
the knowledge of Seller, Seller is in compliance with, is not in default or
violation in any material respect under, and has not been charged with or
received any notice at any time of any material violation of any statute, law,
ordinance, regulation, rule, decree or other regulation in the Federation of St.
Kitts & Nevis that would constitute a Seller Material Adverse
Effect;

       

              (b)           To
the knowledge of Seller, Seller is not subject to any judgment, order or decree
entered in any lawsuit or proceeding applicable to its business and operations
that would result in a Seller Material Adverse Effect; and

       

              (c)           To
the knowledge of Seller, Seller has duly filed all reports and a return required
to be filed by it with governmental authorities in the Federation of St. Kitts
& Nevis and has obtained all governmental permits and other governmental
consents, except as may be required after the execution of this
Agreement.  To the knowledge of Seller, all of such permits and
consents are in full force and effect, and no proceedings for the suspension or
cancellation of any of them, and no investigation relating to any of them, is
pending or to the knowledge of Seller, threatened, and none of them will be
adversely affected by the consummation of this Agreement.

      

      
        
           

        

        
          3

          
            

          

        

        
           

        

      

      3.6 Filings, Consents and
Approvals. To the knowledge of Seller, no filing or registration with, no
notice to and no permit, authorization, consent, or approval of any public or
governmental body or authority or other person or entity is necessary for the
consummation by Seller of the transactions contemplated by this Agreement, other
than filing a change of title to the Patents.

       

      3.7 Investor
Representations.  The Seller acknowledges and agrees that the
Shares representing the Purchase Price will be offered and sold to the Seller
without such offers and sales being registered under the United States
Securities Act of 1933, as amended (the “Securities
Act”).  As such, the Seller further acknowledges and agrees
that all Shares will, upon issuance, be “restricted securities” within the
meaning of the Securities Act.

       

      3.8 Share
Certificates.  The Seller acknowledges and agrees that legend
in substantially the following form will be placed on any certificate(s)
evidencing the Shares:

       

      THE
SHARES OF COMMON STOCK EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE 'ACT'), OR UNDER ANY STATE
SECURITIES LAWS. THE SHARES MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE
DISPOSED OF UNLESS A REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE
STATE SECURITIES LAWS WITH RESPECT TO SUCH DISPOSITION IS THEN IN EFFECT OR
UNLESS THE PERSON PROPOSING TO MAKE THE DISPOSITION SHALL FURNISH, WITH RESPECT
TO SUCH DISPOSITION, AN OPINION OF COUNSEL (BOTH COUNSEL AND OPINION TO BE
SATISFACTORY TO THE CORPORATION) TO THE EFFECT THAT SUCH SALE, TRANSFER,
ASSIGNMENT OR OTHER DISPOSITION WILL NOT INVOLVE ANY VIOLATION OF THE
REGISTRATION PROVISIONS OF THE ACT (OR ANY SUPERSEDING STATUTE) OR ANY
APPLICABLE STATE SECURITIES LAWS.

      

      3.9 Issuance of
Shares.  The Seller represents and warrants to the Purchaser as
follows, and acknowledges that the Purchaser is relying upon such covenants,
representations and warranties in connection with the issuance of the Shares to
the Seller:

       

              (a)           the
Seller has such knowledge, sophistication and experience in business and
financial matters such that it is capable of evaluating the merits and risks of
the investment in the Shares. The Seller has evaluated the merits and risks of
an investment in the Shares.  The Seller can bear the economic risk of
this investment, and is able to afford a complete loss of this
investment;

         

              (b)           the
Seller acknowledges that the Purchaser’s success is subject to a number of
significant risks, including the risk that the Purchaser will not be able to
finance its plan of operations.  The Seller further acknowledges that
(i) the Purchaser has limited cash and working capital, (ii) the Purchaser will
have to raise additional capital in order to finance its plan of operations
which capital may be raised by the issuance of additional shares of its common
stock which will result in dilution to the Seller, and (iii) the Purchaser is
working on the Financing but there is no assurance that the Financing will be
completed;

       

              (c)           the
Shares will be acquired by the Seller for investment for the Seller's own
account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof, and, that the Seller does not have any
contract, undertaking, agreement or arrangement with any person to sell,
transfer or grant participations to such person or to any third person, with
respect to any of the Shares;

      

      

              (d)           the
Seller has been afforded access to information about the Purchaser and the
Purchaser’s financial condition, results of operations, business, properties,
management and prospects sufficient it to evaluate its investment in the
Shares.  The Seller further represents that it has had an opportunity
to ask questions and receive answers from representatives of the Purchaser
regarding the terms and conditions of the offerings completed by the Purchaser
and the business, properties, prospects and financial condition of the
Purchaser, each as is necessary to evaluate the merits and risks of investing in
the Shares.  The Seller believes it has received all the information
it considers necessary or appropriate for deciding whether to purchase the
Shares.  The Seller has had full opportunity to discuss this
information with the Seller’s legal and financial advisers prior to execution of
this Agreement;

       

      
        
           

        

        
          4

          
            

          

        

        
           

        

      

              (e)           the
Seller acknowledges that the Purchaser will rely on these representations in
completing the issuance of the Shares to the Seller;

       

              (f)           the
Seller acknowledges that the offering of the Shares by the Purchaser has not
been reviewed by the United States Securities and Exchange Commission or any
state securities regulatory authority; and

       

              (g)           this
Agreement has been duly authorized, validly executed and delivered by the
Seller.

      

      ARTICLE
4

       

      REPRESENTATIONS
AND WARRANTIES OF PURCHASER

       

      To induce
the Seller to execute, deliver and perform this Agreement, and in
acknowledgement of Seller’s reliance on the following representations and
warranties, the Purchaser hereby represents and warrants to the Seller as
follows as of the date hereof and as of the Closing Date:

       

      4.1 Organization.  The
Purchaser is a corporation duly incorporated, validly existing and in good
standing under the laws of the State of Nevada, with the power and authority to
conduct its business as it is now being conducted and to own and lease its
properties and assets.

       

      4.2 Share Capital. The
Purchaser has authorized capital consisting of 65,000,000 shares of Common Stock
and 10,000,000 shares of Preferred Stock of which 2,400,000 shares of Common
Stock and zero shares of Preferred Stock are issued and outstanding prior to
Closing. Upon the completion of the transactions contemplated by this Agreement,
the Purchaser will have 2,650,000 shares of Common Stock and zero shares of
Preferred Stock issued and outstanding.  There are no options,
warrants, calls, rights, commitments or agreements of any character, written or
oral, to which the Purchaser is a party or by which it is obligated to issue,
deliver, sell, repurchase or redeem, or cause to be issued, delivered, sold,
repurchased or redeemed, any shares of the capital stock of the Purchaser or
obligating the Purchaser to grant, extend, accelerate the vesting of, change the
price of, otherwise amend or enter into any such option, warrant, call, right,
commitment or agreement.  The Purchaser has no outstanding or
authorized stock appreciation, phantom stock, profit participation, or other
similar rights or plans.

       

      4.3 Issuance of the
Shares.  The Shares are duly authorized and, when issued and
paid for in accordance with this Agreement, will be duly and validly issued,
fully paid and non-assessable, free and clear of all liens.

       

      4.4 Listing.  The
Purchaser is a reporting company under the United States Securities and Exchange
Act of 1934, as amended, and its shares of Common Stock are registered for sale
and are quoted for trading on the OTC Bulletin Board under the symbol
KNDT.

       

      4.5 SEC Reports; Financial
Statements.  The Purchaser has filed all reports required to be
filed by it under the Securities Act and the Securities Exchange Act of 1934, as
amended, including pursuant to Section 13(a) or 15(d) thereof, for the two years
preceding the date hereof (or such shorter period as the Purchaser was required
by law to file such material) (the foregoing materials, including the exhibits
thereto, being collectively referred to herein as the “SEC Reports”) on a timely
basis or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension.  As of
their respective dates, the SEC Reports complied in all material respects with
the requirements of the Securities Act and the Exchange Act and the rules and
regulations of the Commission promulgated thereunder, and none of the SEC
Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which
they were made, not misleading.  The financial statements of the
Purchaser included in the SEC Reports comply in all material respects with
applicable accounting requirements and the rules and regulations of the
Commission with respect thereto as in effect at the time of
filing.  Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a
consistent basis during the periods involved (“GAAP”), except as may be
otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by
GAAP, and fairly present in all material respects the financial position of the
Purchaser and its consolidated subsidiaries as of and for the dates thereof and
the results of operations and cash flows for the periods then ended, subject, in
the case of unaudited statements, to normal, immaterial, year-end audit
adjustments.

       

      
        
           

        

        
          5

          
            

          

        

        
           

        

      

      4.6 Power and
Authority.  The Purchaser has the power and authority to
execute, deliver, and perform this Agreement and the other agreements and
instruments to be executed and delivered by it in connection with the
transactions contemplated hereby, and the execution, delivery and performance of
the Agreement by the Purchaser has been duly authorized.  This
Agreement is, and, when such other agreements and instruments are executed and
delivered, the other agreements and instruments to be executed and delivered by
the Purchaser in connection with the transactions contemplated hereby shall be,
the valid and legally binding obligations of the Purchaser, enforceable in
accordance with their respective terms.

       

      4.7 Broker’s or Finder’s
Fees.  The Purchaser has not authorized any person to act as
broker, finder, or in any other similar capacity in connection with the
transactions contemplated by this Agreement and other than the fee to Pacific
Wave and the Escrow Shares Agent, the Seller shall have no liability for payment
of any such fee arising through the Purchaser.

       

      4.8 No
Conflict.  Neither the execution and delivery by the Purchaser
of this Agreement and of the other agreements and instruments to be executed and
delivered by the Purchaser in connection with the transactions contemplated
hereby or thereby, nor the consummation by the Purchaser of the transactions
contemplated hereby, will or do violate or conflict with: (a) any foreign or
local law, regulation, ordinance, governmental restriction, order, judgment or
decree applicable to the Purchaser; (b) any provision of any charter, bylaw, or
(c) under any material agreement to which the Purchaser is a party.

       

      4.9 Required
Consents.  No permit or approval, authorization, consent,
permission, or waiver to or from any person, or notice, filing, or recording to
or with, any person is necessary for the execution and delivery of this
Agreement and the other agreements and instruments to be executed and delivered
by the Purchaser in connection with the transactions contemplated hereby, or the
consummation by the Purchaser of the transactions contemplated
hereby.

       

      4.10 Litigation.  There
are no proceedings pending or, to the knowledge of the Purchaser, threatened
against the Purchaser which (i) seek to restrain or enjoin the consummation of
the Agreement or the transactions contemplated hereby or (ii) could reasonably
be expected to have a material adverse effect on the Purchaser or its abilities
to perform its obligations under the Agreement and the other agreements and
instruments to be executed and delivered by the Purchaser in connection with the
transactions contemplated hereby.

       

      4.11 Tax
Matters.  All Federal, state and other tax returns and reports
of the Purchaser required by law to be filed have been duly filed, and all
federal, state and other taxes, assessments, fees and other governmental charges
upon the Purchaser with respect to its properties, assets, incomes, franchises
or business which are due and payable have been paid or a reasonable reserve for
such payment established on the Purchaser’s balance sheet.

       

      
        
           

        

        
          6

          
            

          

        

        
           

        

      

      ARTICLE
5

       

      COVENANTS
OF THE SELLER PRIOR TO CLOSING

       

      5.1 Required
Approvals.  As promptly as practicable after the date of this
Agreement, the Seller shall make all filings required by foreign or local law to
be made by them in order to consummate the transactions contemplated
hereby.  The Seller shall cooperate with the Purchaser with respect to
all filings that the Purchaser elects to make or is required by law to make in
connection with the transactions contemplated hereby.

       

      5.2 Prohibited
Actions.  Except as provided herein below, in no event, without
the prior written consent of the Purchaser, shall the Seller:

       

              (a) permit
any of the Patents to be subjected to any claim or encumbrance, except claims or
encumbrances that the Seller believes, in its sole judgment, are necessary to
continue development of the Patents in the ordinary course of business and
consistent with past practice;

       

              (b) waive
any claims or rights respecting the Patents, or sell, transfer, or otherwise
dispose of any of the Patents; or

       

              (c) dispose
of any interest in any of the Patents, or permit any rights in any of the
Patents to lapse into default or in non-compliance with all and any regulatory
or governmental requirement.

       

      

      5.3 Access.  From
the date of this Agreement to the Closing Date, the Seller shall provide the
Purchaser with such information and access as the Purchaser may from time to
time reasonably request regarding the Patents.

       

      ARTICLE
6

       

      CONDITIONS
TO THE SELLER’S OBLIGATIONS

       

      Each of
the obligations of the Seller to be performed hereunder shall be subject to the
satisfaction (or waiver by the Seller) at or prior to the Closing Date of each
of the following conditions:

       

      6.1 Representations and
Warranties; Performance.  The Purchaser shall have performed
and complied in all respects with the covenants and agreements contained in this
Agreement required to be performed and complied with by it at or prior to the
Closing Date, the representations and warranties of the Purchaser set forth in
this Agreement shall be true and correct in all respects as of the date hereof
and as of the Closing Date as though made at and as of the Closing Date (except
as otherwise expressly contemplated by this Agreement), and the execution and
delivery of this Agreement by the Purchaser and the consummation of the
transactions contemplated hereby shall have been duly and validly authorized by
the Purchaser’s Board of Directors, and the Seller shall have received a
certificate to that effect signed by the secretary of the
Purchaser.

       

      6.2 Consents.  All
required approvals, consents and authorizations shall have been
obtained.

       

      6.3 Litigation.  No
Litigation shall be threatened or pending against the Purchaser or the Seller
that, in the reasonable opinion of counsel for the Seller, could result in the
restraint or prohibition of any such party, or the obtaining of damages or other
relief from such party, in connection with this Agreement or the consummation of
the transactions contemplated hereby.

       

      6.4 Documents Satisfactory in
Form and Substance.  All agreements, certificates, and other
documents delivered by the Purchaser to the Seller hereunder shall be in form
and substance satisfactory to counsel for the Seller, in the exercise of such
counsel’s reasonable judgment.

       

      6.5 Due
Diligence.  The Seller shall have completed its due diligence
review of the Purchaser and shall have been satisfied with the findings
thereof.

       

      
        
           

        

        
          7

          
            

          

        

        
           

        

      

      ARTICLE
7

       

      CONDITIONS
TO THE PURCHASER’S OBLIGATIONS

       

      Each of
the obligations of the Purchaser to be performed hereunder shall be subject to
the satisfaction (or the waiver by the Purchaser) at or prior to the Closing
Date of each of the following conditions:

       

      7.1 Representations and
Warranties; Performance.  The Seller shall have performed and
complied in all respects with the covenants and agreements contained in this
Agreement required to be performed and complied with by them at or prior to the
Closing Date, the representations and warranties of the Seller set forth in this
Agreement shall be true and correct in all respects as of the date hereof and as
of the Closing Date as though made at and as of the Closing Date (except as
otherwise expressly contemplated by this Agreement), and the execution and
delivery of this Agreement by the Seller and the consummation of the
transactions contemplated hereby shall have been duly and validly authorized by
the Seller’s Board of Directors, and the Purchaser shall have received a
certificate to that effect signed by the secretary of the Seller.

       

      7.2 Consents.  All
required approvals, consents and authorizations shall have been
obtained.

       

      7.3 No
Litigation.  No Litigation shall be threatened or pending
against the Purchaser or the Seller that, in the reasonable opinion of counsel
for the Purchaser, could result in the restraint or prohibition of any such
party, or the obtaining of damages or other relief from such party, in
connection with this Agreement or the consummation of the transactions
contemplated hereby.

       

      7.4 Due
Diligence.  The Purchaser shall have completed its due
diligence review of the Patents and shall have been satisfied with the findings
thereof.

       

      7.5 Proof of Ownership of the
Assets.  The Seller shall have delivered to the Purchaser
copies of instruments evidencing its ownership of the Patents.

       

      ARTICLE
8

       

      COVENANTS
OF THE SELLER AND THE PURCHASER FOLLOWING CLOSING

       

      8.1 Allocation of Purchase
Price; Transfer Taxes.

       

              (a) Consistent
with applicable tax rules, the Purchaser shall allocate the Purchase Price to
the Patents.  The Purchaser shall prepare and file, in a timely
fashion, forms in a manner consistent with such allocation with the relevant tax
authority.  

       

              (b) All
sales, transfer, and similar taxes and fees (including all recording fees, if
any) incurred in connection with this Agreement and the transactions
contemplated hereby shall be borne by the Seller and the Seller shall file all
necessary documentation with respect to such taxes.

       

      8.2 Further
Assurances.  Subject to the terms and conditions of this
Agreement, each party agrees to use all of its reasonable efforts to take, or
cause to be taken, all actions and to do or cause to be done, all things
necessary and proper or advisable to consummate and make effective the
transactions contemplated by this Agreement (including the execution and
delivery of such further instruments and documents) as the other party may
reasonably request.

       

      8.3 Nondisclosure of Proprietary
Data.  The Parties shall hold in a fiduciary capacity for the
benefit of each other all secret or confidential information, knowledge or data
relating to each other or any of their affiliated companies, and their
respective businesses, which shall not be or become public
knowledge.  Neither Party, without the prior written consent of the
other, or as may otherwise be required by law or legal process, shall
communicate or divulge either before or after the Closing Date any such
information, knowledge or data to anyone other than the other Party and those
designated by the other Party in writing, or except as required by applicable
law.

       

      
        
           

        

        
          8

          
            

          

        

        
           

        

      

      ARTICLE
9

       

      SURVIVAL
AND INDEMNITY

       

      9.1 Survival of Representations,
Warranties, etc.  Each of the representations, warranties,
agreements, covenants and obligations herein is material and shall be deemed to
have been relied upon by the other party or parties and shall survive for a
period of twelve (12) months after the Closing and shall not merge in the
performance of any obligation by any party hereto.  All rights to
indemnification contained in this Agreement shall survive the Closing
indefinitely.

       

      9.2 Indemnification by the
Seller and Purchaser.  The parties shall indemnify, defend, and
hold harmless each other, and the each others representatives, stockholders,
controlling persons and affiliates, at, and at any time after, the Closing, from
and against any and all demands, claim, actions, or causes of action,
assessments, losses, damages (including incidental and consequential damages),
liabilities, costs, and expenses, including reasonable fees and expenses of
counsel, other expenses of investigation, handling, and litigation , and
settlement amounts, together with interest and penalties (collectively, a “Loss” or “Losses”), asserted against,
resulting to, imposed upon, or incurred by the either party, directly or
indirectly, by reason of, resulting from, or arising in connection with: (i) any
breach of any representation, warranty, or agreement of either party contained
in or made pursuant to this Agreement, including the agreements and other
instruments contemplated hereby; (ii) any breach of any representation,
warranty, or agreement of either party contained in or made pursuant to this
Agreement, including the agreements and other instruments contemplated hereby,
as if such representation or warranty were made on and as of the Closing Date;
(iii) any claim by any person for brokerage or finder’s fees or commissions or
similar payments based upon any agreement or understanding alleged to have been
made by any such person with either party in connection this Agreement or any of
the transactions contemplated hereby; and (iv) to the extent not covered by the
foregoing, any and all demands, claims, actions or causes of action,
assessments, losses, damages, liabilities, costs, and expenses, including
reasonable fees and expenses of counsel, other expenses of investigation,
handling, and litigation and settlement amounts, together with interest and
penalties, incident to the foregoing.

       

      The
remedies provided in this Section 9.2 will not be exclusive of or limit any
other remedies that may be available to the either party to this
Agreement.

       

      ARTICLE
10

       

      TERMINATION

       

      10.1 Termination.  This
Agreement may be terminated at any time prior to the Closing Date:

       

              (a) by
mutual written consent of the Seller and the Purchaser;

       

              (b) by
either the Seller or the Purchaser if (i) there shall have been a material
breach of any representation, warranty, covenant or agreement set forth in this
Agreement, on the part of the Purchaser, in the case of a termination by the
Seller, or on the part of the Seller, in the case of a termination by the
Purchaser, which breach shall not have been cured, in the case of a
representation or warranty, prior to Closing or, in the case of a covenant or
agreement, within ten (10) business days following receipt by the breaching
party of notice of such breach, or (ii) any permanent injunction or other order
of a court or other competent authority preventing the consummation of the
transactions contemplated hereby shall have become final and
non-appealable;

       

      
        
           

        

        
          9

          
            

          

        

        
           

        

      

              (c) by
either the Seller or the Purchaser if the transactions contemplated hereby shall
not have been consummated on or before the Closing Date; provided, however, that the
right to terminate this Agreement pursuant to this Section 10.1(c) shall not be
available to any party whose failure to fulfill any obligation under this
Agreement has been the cause of, or resulted in, the failure of the consummation
of the transactions contemplated hereby to have occurred on or before the
aforesaid date; or

       

             (d) By
the Purchaser in the event of an uncured Title Defect as provided in Section 2.2
of this Agreement.

       

      10.2 Effect of
Termination.  Each party’s right of termination under Section
10.1 is in addition to any other rights it may have under this Agreement or
otherwise, and the exercise of a right of termination will not be an election of
remedies.  If this Agreement is terminated pursuant to
Section 10.1, unless otherwise specified in this Agreement, all further
obligations of the parties under this Agreement will terminate; provided, however, that if this
Agreement is terminated by a party because of the breach of this Agreement by
the other party or because one or more of the conditions to the terminating
party’s obligations under this Agreement is not satisfied as a result of the
other party’s failure to comply with its obligations under this Agreement, the
terminating party’s rights to pursue all legal remedies will survive such
termination unimpaired.

       

      ARTICLE
11

       

      MISCELLANEOUS

       

      11.1 Entire
Agreement.  This Agreement, and the other certificates,
agreements, and other instruments to be executed and delivered by the parties in
connection with the transactions contemplated hereby, constitute the sole
understanding of the parties with respect to the subject matter hereof and
supersede all prior oral or written agreements with respect to the subject
matter hereof.

       

      11.2 Parties Bound by Agreement;
Successors and Assigns.  The terms, conditions, and obligations
of this Agreement shall inure to the benefit of and be binding upon the parties
hereto and their respective successors and assigns.

       

      11.3 Amendments and
Waivers.  No modification, termination, extension, renewal or
waiver of any provision of this Agreement shall be binding upon a party unless
made in writing and signed by such party.  A waiver on one occasion
shall not be construed as a waiver of any right on any future
occasion.  No delay or omission by a party in exercising any of its
rights hereunder shall operate as a waiver of such rights.

       

      11.4 Severability.  If
for any reason any term or provision of this Agreement is held to be invalid or
unenforceable, all other valid terms and provisions hereof shall remain in full
force and effect, and all of the terms and provisions of this Agreement shall be
deemed to be severable in nature.  If for any reason any term or
provision containing a restriction set forth herein is held to cover an area or
to be for a length of time which is unreasonable, or in any other way is
construed to be too broad or to any extent invalid, such term or provision shall
not be determined to be null, void and of no effect, but to the extent the same
is or would be valid or enforceable under applicable law, any court of competent
jurisdiction shall construe and interpret or reform this Agreement to provide
for a restriction having the maximum enforceable area, time period and other
provisions (not greater than those contained herein) as shall be valid and
enforceable under applicable law.

       

      11.5 Attorneys’
Fees.  Should any party hereto retain counsel for the purpose
of enforcing, or preventing the breach of, any provision hereof including, but
not limited to, the institution of any action or proceeding, whether by
arbitration, judicial or quasi-judicial action or otherwise, to enforce any
provision hereof or for damages for any alleged breach of any provision hereof,
or for a declaration of such party’s rights or
obligations hereunder, then, whether such matter is settled by negotiation, or
by arbitration or judicial determination, the prevailing party shall be entitled
to be reimbursed by the losing party for all costs and expenses incurred
thereby, including, but not limited to, reasonable attorneys’ fees for the
services rendered to such prevailing party.

       

      
        
           

        

        
          10

          
            

          

        

        
           

        

      

      11.6 Counterparts.  This
Agreement may be executed in one or more counterparts, each of which shall for
all purposes be deemed to be an original and all of which shall constitute the
same instrument.

       

      11.7 Headings.  The
headings of the sections and paragraphs of this Agreement are inserted for
convenience only and shall not be deemed to constitute part of this Agreement or
to affect the construction hereof.

       

      11.8 Expenses.  Except
as specifically provided herein, the Seller and the Purchaser shall each pay all
costs and expenses incurred by it or on its behalf in connection with this
Agreement and the transactions contemplated hereby, including fees and expenses
of its own financial consultants, accountants, and counsel.

       

      11.9 Notices.  All
notices, requests, demands, claims, and other communications which are required
or may be given under this Agreement shall be in writing and shall be deemed to
have been duly given five business days after such notice, request, demand,
claim or other communication is sent, if sent by registered or certified mail,
return receipt requested, postage prepaid; and, in any case, all such
communications must be addressed to the intended recipient at the address set
forth on the first page of this Agreement.  Any party may send any
notice, request, demand, claim, or other communication hereunder to the intended
recipient at the address set forth above using any other means, but no such
notice, request, demand, claim, or other communication shall be deemed to have
been duly given unless and until it actually is received by the intended
recipient. Any party may change the address to which notices, requests, demands,
claims, and other communications hereunder are to be delivered by giving the
other party notice in the manner herein set forth.

       

      11.10 Governing
Law.  This Agreement shall be construed in accordance with and
governed by the laws of the State of Nevada without giving effect to the
principles of choice of law thereof.

       

      11.11 Arbitration.  Any
dispute arising under or in connection with any matter related to this Agreement
or any related agreement shall be resolved exclusively by arbitration in the
City of Las Vegas, Nevada.  The arbitration shall be in conformity
with and subject to the applicable rules and procedures of the American
Arbitration Association.  All parties agree to be (1) subject to the
jurisdiction and venue of the arbitration in the State of Nevada, (2) bound by
the decision of the arbitrator as the final decision with respect to the
dispute, and (3) subject to the jurisdiction of the Superior Court of the State
of Nevada for the purpose of confirmation and enforcement of any award made by
the arbitrator or for any actions seeking injunctive relief.

       

      11.12 References,
etc.

       

              (a) Whenever
reference is made in this Agreement to any Article, Section, or paragraph, such
reference shall be deemed to apply to the specified Article, Section or
paragraph of this Agreement.

       

              (b) Wherever
reference is made in this Agreement to a Schedule, such reference shall be
deemed to apply to the specified Schedule attached hereto, which are
incorporated into this Agreement and form a part hereof.  All terms
defined in this Agreement shall have the same meaning in the Schedules attached
hereto.

       

              (c) Any
form of the word “include” when used herein is not intended to be exclusive
(e.g., “including” means “including, without limitation”).

       

      
        
           

        

        
          11

          
            

          

        

        
           

        

      

      11.13 No Strict
Construction.  The language used in this Agreement will be
deemed to be the language chosen by the parties hereto to express their mutual
intent, and no rule of strict construction will be applied against any
person.

       

      11.14 No Third Party Beneficiary
Rights.  No provision in this Agreement is intended or shall
create any rights with respect to the subject matter of this Agreement in any
third party.

       

      11.15 Such Other
Acts.  The parties hereto shall do all things, take such acts
and execute such documents as are necessary to give effect to the intention
herein contemplated.

       

      11.16 Electronic
Means.  Delivery of an executed copy of this Agreement by
electronic facsimile transmission or other means of electronic communication
capable of producing a printed copy will be deemed to be execution and delivery
of this Agreement as of the date first indicated above.

       

      

      IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be
executed on its behalf as of the date first indicated above.

      
        
          
            
              	 	 	 
	 
      	
                      KINDER
      TRAVEL INC.

                    	 
      
	 
      	 
      	 
      	 
      
	 
      	
                      By:

                    	 
      	 
      
	 
      	 
      	
                      Aaron
      Whiteman

                    	 
      
	 
      	 
      	
                      Title:
      President

                    	 
      
	 
      	 
      	 
      	 
      

            

          

        

      

       

      
        
          
            
              	 	 	 
	 
      	
                      PHOINOS
      OXFORD LIFESCIENCES LIMITED

                    	 
      
	 
      	 
      	 
      	 
      
	 
      	
                      By:

                    	 
      	 
      
	 
      	 
      	
                      Name:
      Lars Christiansen

                    	 
      
	 
      	 
      	
                      Title:
      Director

                    	 
      
	 
      	 
      	 
      	 
      

            

          

        

      

      

        
          
             

          

          
            12

            
              

            

          

           

        
SCHEDULE
A

      

      DESCRIPTION
OF PATENTS

      

      All
patents are registered with the Danish Patent-og Varemaerkestyrelsen (Patent and
Trademark Office) at Helgeshoj Alle 81, 2630 Taastrup, Denmark and the United
Kingdom Intellectual Property Office at Concept House, Cardiff Road, Newport,
South Wales, United Kingdom.

      

      
        	
                DK
      Patent #

              	
                UK
      Patent #

              	
                Description

              
	
                PA200900070

              	
                GB0906484.1

              	
                Use
      of prostaganin for treatment of prostate
cancer

              

      

      

      
        This
invention relates to our novel prostate cancer peptide called prostaganin.
Prostaganin is a 21-amino compound which is highly active toward both
androgen-dependent and androgen-independent human prostate cancer
cells.  Hence, prostaganin can specifically target prostate cancer
cells and accordingly, prostaganin has the potential to cure both primary and
methastatic tumors.

         

      

      
        	
                DK
      Patent #

              	
                UK
      Patent #

              	
                Description

              
	
                PA200900071

              	
                GB0906490.8

              	
                Use
      of tetanolic acid for treatment of breast
cancer

              

      

      

      This
invention relates to a novel lipid designated tetanolic acid which induces the
start of cell death and stops the cell cycle progression in breast tumor cells.
Thus, tetanolic acid shows the potential for curing breast cancer by stopping
cell growth at a very early time point after detection of cancerous breast
cells.

      
         

      

      
        	
                DK
      Patent #

              	
                UK
      Patent #

              	
                Description

              
	
                PA200900074

              	
                GB0906496.5

              	
                Method
      for inducing breast carcinoma stem cell
death

              

      

      

      This
invention relates to an improved method for the purification of undifferentiated
stem cells from solid breast carcinomas that are normally resistant to
conventional therapies. Such stem cells are valuable for identifying new tumor
markers and novel therapeutic targets both for early diagnosis and for targeted
therapeutic strategies. Such therapeutic strategies are based on cytokine
neutralizing antibodies against interleukin-4 (IL-4) and interleukin-10 (IL-10)
and antibodies reactive with HMW-MAA which are found in high levels in stem
cells from solid breast carcinomas.

      
        
           

        

        
          13

          
            

          

        

         

      

      SCHEDULE
B

       

      SECURITIES ESCROW AGREEMENT

       

      SECURITIES ESCROW AGREEMENT,
dated as of April 15, 2009 (this “Agreement”), by and
among KINDER TRAVEL INC., a company organized under the laws of Nevada (the
“Company”),
PHOINOS OXFORD LIFESCIENCES LIMITED, a company organized under the laws of the
Federation of St. Kitts & Nevis (“Phoinos”), and WALL
STREET TRANSFER AGENTS, INC. (“Escrow
Agent”).

       

      WHEREAS, the Company has
entered into an Asset Purchase Agreement, dated the date hereof (the “Purchase Agreement”),
with Phoinos pursuant to which the Company has agreed to purchase three (3)
patents registered to Phoinos.

       

      WHEREAS, at closing of the
Purchase Agreement, the Company will issue 250,000 shares of the common stock of
the Company in the name of Phoinis (the “Escrow Shares”),

       

      WHEREAS, Phoinos has agreed as
a condition of the Purchase Agreement to deposit all of the Shares in escrow as
hereinafter provided.

       

      WHEREAS, the Company and
Phoinos desire that the Escrow Agent accept the Escrow Shares, in escrow, to be
held and disbursed as hereinafter provided.

       

      THEREFORE,
IT IS AGREED:

       

      ARTICLE
1   Appointment of Escrow
Agent.

       

      The
Company and Phoinos hereby appoint the Escrow Agent to act in accordance with
and subject to the terms of this Agreement and the Escrow Agent hereby accepts
such appointment and agrees to act in accordance with and subject to such
terms.

       

      ARTICLE
2   Term of Escrow
Agreement.

       

      This
Agreement shall terminate on the issuance of all the Escrow Shares to
Phoinos.

       

      ARTICLE
3   Deposit of Escrow
Shares.

       

      On the
date hereof, the Company shall deliver to the Escrow Agent certificates
representing the Escrow Shares, to be held and disbursed subject to the terms
and conditions of this Agreement.

       

      ARTICLE
4   Disbursement of the Escrow
Shares.

       

      Phoinos
shall provide the Escrow Agent with a written notice of request for the issuance
of Escrow Shares, with a copy to the Company, such notice to include, the name,
address, and Tax Identification Number, if applicable, of the registered holder
of the Warrant Shares, and the name and address of the party to whom the Escrow
Shares shall be delivered to, provided, that in no event shall the aggregate
number of shares released in any 3 month period exceed 10% of the total number
shares placed in escrow. Upon receipt of the Notice, the Company shall have
three business days to notify the Escrow Agent and Phoinos, in writing, of its
objection (and the reason therefor) to the release of the Escrow Shares, in
which case, the Escrow Agent shall not release any Escrow Shares until it
receives joint written instructions from the Company and Phoinos to do
so.  Absent such objection, the Escrow Agent shall release that number
of Escrow Shares equal to the number of Shares set forth in the Notice to the
applicable party set forth in the Notice on the fourth business day following
its receipt of the Notice.

       

      
        
           

        

        
          14

          
            

          

        

        
           

        

      

      ARTICLE
5   Legend.

       

      Each
certificate for Warrant Shares issued under this Agreement shall bear a legend
as follows:

      

      THE
SHARES OF COMMON STOCK EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE 'ACT'), OR UNDER ANY STATE
SECURITIES LAWS. THE SHARES MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE
DISPOSED OF UNLESS A REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE
STATE SECURITIES LAWS WITH RESPECT TO SUCH DISPOSITION IS THEN IN EFFECT OR
UNLESS THE PERSON PROPOSING TO MAKE THE DISPOSITION SHALL FURNISH, WITH RESPECT
TO SUCH DISPOSITION, AN OPINION OF COUNSEL (BOTH COUNSEL AND OPINION TO BE
SATISFACTORY TO THE CORPORATION) TO THE EFFECT THAT SUCH SALE, TRANSFER,
ASSIGNMENT OR OTHER DISPOSITION WILL NOT INVOLVE ANY VIOLATION OF THE
REGISTRATION PROVISIONS OF THE ACT (OR ANY SUPERSEDING STATUTE) OR ANY
APPLICABLE STATE SECURITIES LAWS.

       

      ARTICLE
6   Rights in the Escrow
Shares.

       

      6.1 Voting Rights as a
Shareholder.  Phoinos’s agrees that it only has the right to
vote the Escrow Shares that have been distributed by the Escrow Agent to
Phoinos. Phoinos irrevocably waives its rights to vote any Escrow shares still
held by the Escrow Agent (the “Remaining Shares”) and irrevocably assigns the
right to vote the Remaining Shares to Global Developments Inc., a Delaware
Corporation

       

      6.2 Dividends and Other
Distributions in Respect of the Escrow Shares.  All dividends
and other distributions payable in cash, securities or other property with
respect to the Escrow Shares shall be paid to Phoinos and shall become part of
the Escrow Shares.

       

      6.3 Restrictions on
Transfer.  Except as permitted under the terms of this
Agreement, Phoinos shall have no right whatsoever to transfer all or a portion
of the Escrow Shares. During the term of this Agreement, Phoinos shall not
pledge or grant a security interest in the Escrow Shares or grant a security
interest in its rights under this Agreement.

       

      ARTICLE
7   Concerning the Escrow
Agent.

       

      7.1 Good Faith
Reliance.  The Escrow Agent shall not be liable for any action
taken or omitted by it in good faith and in the exercise of its own best
judgment, and may rely conclusively and shall be protected in acting upon any
order, notice, demand, certificate, opinion or advice of counsel (including
counsel chosen by the Escrow Agent), statement, instrument, report or other
paper or document (not only as to its due execution and the validity and
effectiveness of its provisions, but also as to the truth and acceptability of
any information therein contained) which is believed by the Escrow Agent to be
genuine and to be signed or presented by the proper person or
persons.  The Escrow Agent shall not be bound by any notice or demand,
or any waiver, modification, termination or rescission of this Agreement unless
evidenced by a writing delivered to the Escrow Agent signed by the proper party
or parties and, if the duties or rights of the Escrow Agent are affected, unless
it shall have given its prior written consent thereto.

       

      
        
           

        

        
          15

          
            

          

        

        
           

        

      

      7.2 Indemnification.  The
Escrow Agent shall be indemnified and held harmless, jointly and severally, by
the Company and Phoinos from and against any expenses, including reasonable
counsel fees and disbursements, or loss suffered by the Escrow Agent in
connection with any action, suit or other proceeding involving any claim which
in any way, directly or indirectly, arises out of or relates to this Agreement,
the services of the Escrow Agent hereunder, or the Escrow Shares held by it
hereunder, other than expenses or losses arising from the gross negligence or
willful misconduct of the Escrow Agent.  Promptly after the receipt by
the Escrow Agent of notice of any demand or claim or the commencement of any
action, suit or proceeding, the Escrow Agent shall notify the other parties
hereto in writing.  In the event of the receipt of such notice, the
Escrow Agent, in its sole discretion, may commence an action in the nature of
interpleader in an appropriate court to determine ownership or disposition of
the Escrow Shares or it may deposit the Escrow Shares with the clerk of any
appropriate court or it may retain the Escrow Shares pending receipt of a final,
non-appealable order of a court having jurisdiction over all of the parties
hereto directing to whom and under what circumstances the Escrow Shares are to
be disbursed and delivered.  The provisions of this Section 8.2 shall
survive in the event the Escrow Agent resigns or is discharged pursuant to
Sections 8.5 or 8.6 below.

       

      7.3 Compensation.  The
Escrow Agent shall be entitled to reasonable compensation from the Company for
all services rendered by it hereunder, as set forth on Exhibit A hereto. The Escrow
Agent shall also be entitled to reimbursement from the Company for all expenses
paid or incurred by it in the administration of its duties hereunder including,
but not limited to, all reasonable counsel, advisors’ and agents’ fees and
disbursements and all taxes or other governmental charges.

       

      7.4 Further
Assurances.  From time to time on and after the date hereof,
the Company and Phoinos shall deliver or cause to be delivered to the Escrow
Agent such further documents and instruments and shall do or cause to be done
such further acts as the Escrow Agent shall reasonably request to carry out more
effectively the provisions and purposes of this Agreement, to evidence
compliance herewith or to assure itself that it is protected in acting
hereunder.

       

      7.5 Resignation.  The
Escrow Agent may resign at any time and be discharged from its duties as escrow
agent hereunder by its giving the other parties hereto written notice and such
resignation shall become effective as hereinafter provided.  Such
resignation shall become effective at such time that the Escrow Agent shall turn
over to a successor escrow agent, appointed by the Company, the Escrow Shares
held hereunder.  If no new escrow agent is so appointed within the 60
day period following the giving of such notice of resignation, the Escrow Agent
may deposit the Escrow Shares with any court it reasonably deems
appropriate.  Upon resignation, the Escrow Agent shall reimburse the
Company pro-rata for any annual fees paid as set forth in Exhibit A

       

      7.6 Discharge of Escrow
Agent.  The Escrow Agent shall be discharged from its duties as
escrow agent hereunder if so requested in writing at any time by the other
parties hereto; provided, however, that such
resignation shall become effective only upon acceptance of appointment by a
successor escrow agent as provided in Section 8.5.

       

      
        
           

        

        
          16

          
            

          

        

        
           

        

      

      7.7 Liability.  Notwithstanding
anything herein to the contrary, the Escrow Agent shall not be relieved from
liability hereunder for its own gross negligence or its own willful
misconduct.

       

      ARTICLE
8   Miscellaneous.

       

      8.1 Governing
Law.  This Agreement shall for all purposes be deemed to be
made under and shall be construed in accordance with the laws of the State of
Nevada.  Each of the parties hereby agrees that any action, proceeding
or claim against it arising out of or relating in any way to this Agreement
shall be brought and enforced in the courts of the State of Nevada, and
irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive.
Each of the parties hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Any such process or
summons to be served upon each of the Company, Phoinos and the Escrow Agent may
be served by transmitting a copy thereof by registered or certified mail, return
receipt requested, postage prepaid, addressed to it at the address set forth in
Section 9.6 hereof. Such mailing shall be deemed personal service and shall be
legal and binding upon each of the Company, Phoinos and the Escrow Agent in any
action, proceeding or claim.

       

      8.2 No Third Party
Beneficiaries.  This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns and is
not for the benefit of, nor may any provision hereof be enforced by, any other
person or entity.

       

      8.3 Entire
Agreement.  This Agreement contains the entire agreement of the
parties hereto with respect to the subject matter hereof and, except as
expressly provided herein, may not be changed or modified except by an
instrument in writing signed by the party to the charged.

       

      8.4 Headings.  The
headings contained in this Agreement are for reference purposes only and shall
not affect in any way the meaning or interpretation thereof.

       

      8.5 Binding
Effect.  This Agreement shall be binding upon and inure to the
benefit of the respective parties hereto and their legal representative,
successors and assigns.

       

      8.6 Notices.  Any
notice or other communication required or which may be given hereunder shall be
in writing and either be delivered personally or by private national courier
service, or be mailed, certified or registered mail, return receipt requested,
postage prepaid, and shall be deemed given when so delivered personally or, if
sent by private national courier service, on the next business day after
delivery to the courier, or, if mailed, two days after the date of mailing, as
follows:

       

      
        
          
            
              
                
                  
                    	If to the Company,
      to:	 	 
	 	

                            Kinder
      Travel Inc.

                            20385
      64 Avenue

                            Langley,
      BC   V2Y1N5

                            Fax:
      (604) 514-1990

                            Attention:
      Aaron Whiteman

                          	 
	If to Phoinos,
      to:	 	 
	 	
                            Phoinos
      Oxford Lifesciences Limited

                            c/o
      Global Corporate and Trust Management Ltd.

                            PO Box
      555 Hunkins Plaza, Main Street,

                            Charlestown, Nevis,
      West Indies.

                            Fax:  (869)
      469-2248

                            Attention:
      Lars Christiansen

                          	 
	If to the Escrow
      Agent, to:	 	 
	 	
                            Wall
      Street Transfer Agents, Inc.

                            12492
      Harris Road

                            Pitt
      Meadows, BC

                            Canada V3Y
      2J4

                            Fax:  (604)
      465-7485

                          	 
	And, if to Global
      Developments Inc., for the purposes of Section 6.1 only, to:	 	 
	 	
                            Global
      Developments Inc.

                            1960 – 143 Street

                            Surrey,
      BC

                            Canada    V4A
      7Z2

                            Fax:
      604-538-5575

                            Attn:
      Daniel Baxter

                          	 
	 	 	 

                  

                

              

            

          

        

      

      The
parties may change the persons and addresses to which the notices or other
communications are to be sent by giving written notice to any such change in the
manner provided herein for giving notice.

       

      8.7 Counterparts.  This
Agreement may be executed in several counterparts each one of which shall
constitute an original and may be delivered by facsimile transmission and
together shall constitute one instrument.

      

       

      [Signature page
follows]

      
        
           

        

        
          17

          
            

          

        

         

      

       

      IN WITNESS WHEREOF, the
execution of this Securities Escrow Agreement as of the date first above
written.

      
      

       

      
        	 	 	 	 
	 	KINDER
      TRAVEL INC.	 	 
	 	________________________	 	 
	 	Dr. Aaron Whiteman,
      President	 	 
	 	 	 	 
	 	PHOINOS
      OXFORD LIFESCIENCES LIMITED	 	 
	 	________________________	 	 
	 	Lars Christiansen,
      Director	 	 
	 	 	 	 
	 	WALL STREET
      TRANSFER AGENTS, INC.	 	 
	 	________________________	 	 
	 	Adelle Thoms,
      Director	 	 
	 	 	 	 
	 	
                For
      purposes of Section 6.1 only:

                GLOBAL
      DEVELOPMENTS INC.

              	 	 
	 	________________________	 	 
	 	Daniel Baxter,
      Director	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 

      

      EXHIBIT
A

       

      Escrow Agent
Fees

       

      $250
initial fee, to be paid at closing, for acting agent escrow fee.

       

      An annual
fee equal to one-quarter of one percent (0.25%) of the value of the remaining
escrow shares then held by the escrow agent based upon the average closing price
of the Company’s common stock, as reported by the OTC Bulletin Board, for the 10
trading days preceding the closing date and each subsequent anniversary
thereafter (the “determination date”). The annual fee will be payable within 15
days of the determination date with the exception of the first annual fee which
shall be payable at closing. Notwithstanding the foregoing, in no event shall an
annual fee exceed $3,000 for any one year period, nor be less than $500 for any
one year period (subject, however, to pro-ration as described in paragraph
7.5).

      

        
          
             

          

          
            18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]